Engineered red blood cells carrying PCSK9 inhibitors persistently lower LDL and prevent obesity
Rhogerry Deshycka(Boston Children's Hospital), Novalia Pishesha(Broad Institute)
Cited by 4
Related Papers
Transcriptional divergence and conservation of human and mouse erythropoiesis
|Proceedings of the National Academy of Sciences|2014|89
Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
|Cancer Immunology Research|2018|82
An antibody from single human V <sub>H</sub> -rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion
|Science Immunology|2022|60
Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanism
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3
Engineered Red Blood Cells Carrying PCSK9 Inhibitors Persistently Lower LDL and Prevent Obesity
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0